Status:
COMPLETED
FAST Mapping During Atrial Fibrillation
Lead Sponsor:
University Health Network, Toronto
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide with a prevalence of 8% in the elderly. AF is responsible for frequent hospitalizations, stroke, heart failure and mortality. A...
Eligibility Criteria
Inclusion
- All patients must be over the age 18 and have a clinical indication for their first catheter ablation of AF because of symptomatic AF.
- This will include patients with either high burden paroxysmal (\>4 self-terminating episodes of AF within the last 6 months with two episodes lasting at least 6 hours within the last year) or persistent AF (lasting ≥7 days, but which can still be converted to sinus rhythm).
Exclusion
- The major exclusion criteria will include:
- long-standing persistent AF (ie. AF which cannot be converted to sinus rhythm, or where multiple attempts at restoring sinus rhythm have failed)
- rheumatic valvular disease
- hypertrophic cardiomyopathy
- uncorrected cardiac shunts (eg. secundum ASD)
- severe mitral regurgitation or mechanical mitral valve
- left atrial size \>55 mm (echo derived parasternal long axis view).
Key Trial Info
Start Date :
February 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2019
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT02271152
Start Date
February 1 2015
End Date
February 1 2019
Last Update
March 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G 2C4